Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Lonza has announced investment plans for technology and facility improvements to its antibody drug conjugate (ADC) clinical manufacturing facility in Visp, Switzerland. The planned upgrades include the introduction of single-use technology for...

Rentschler Biotechnologie GmbH, a contract manufacturing organization for the development and production of biopharmaceuticals, is expanding its manufacturing capacity. The company is adding a 2,000-L single-use bioreactor to its facility in...

ScinoPharm Taiwan, Ltd. and TaiGen Biotechnology, a pharmaceutical company based in Taipei, Taiwan, have signed a manufacturing contract for the clinical supply of the active pharmaceutical ingredient (API) for burixafor, a new chemical entity...

The contract research organization Celerion has established a business presence in Singapore, lead by Dr. Chew Lan Chong, who has been appointed as executive director, medical research. He will lead Celerion's business operations...

Packaging Coordinators, Inc. (PCI) has announced the addition of Tim Brown to its Global Clinical Services staff, assuming the role of director of project management for North American operations. Brown is transitioning from PCI's commercial...

To address current and future requirements in compendial and guidelines from the International Conference on Harmonization (ICH) for testing of elemental impurities, Almac has invested in inductively coupled plasma-mass spectrometry (ICP-MS)...

Frontage Labs, a contract manufacturing organization, plans to expand its chemistry, manufacturing and controls (CMC) facility in Exton, Pennsylvania. The renovation plan, which involves two phase, includes incremental capacity expansions...

AMRI has signed a definitive agreement to acquire all of the outstanding membership interests of Oso Biopharmaceuticals Manufacturing, LLC  for $110 million in cash. OsoBio is a contract manufacturer of injectable drug products, including...